FASLODEX

Solution for injection, 250 mg/5ml
RxActive license

Active substance (INN)

fulvestrant

Pharmaceutical form

Pharmaceutical formSolution for injection
Strength250 mg/5ml
PackagingDva napunjena injekciona šprica (2x5ml) u kartonskoj kutiji.
ManufacturerAstraZeneca UK Limited, United Kingdom
Therapeutic groupAntineoplastic and immunomodulating agents (L02BA03)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateMay 15, 2012

Analogs in Montenegro

4

Other medicines with the same active substance

FASELIGORx
Solution for injection in pre-filled syringe, 250 mgLaboratorios Farmalan S.A.
FULVESTRANT SANDOZRx
Solution for injection in pre-filled syringe, 250mgFareva Unterach GmbH
FULVESTRANT STADARx
Solution for injection in pre-filled syringe, 250mgStada Arzneimittel AG
FULWESTRANT ACCORDRx
Solution for injection in pre-filled syringe, 250mg/5mlAccord Healthcare Polska Sp. z o.o. Magazyn Importera
Source: CInMED register